| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |